Search

everythinglearnresearchcommunity

for

Search:↓

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

Doctors need to be better prepared to assess and treat obesity in patients.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Finasteride can reduce fertility in some men, but stopping it increases sperm count.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

A systematic approach is crucial for managing hair loss in women.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hair loss from mood stabilizers is common but can be managed without stopping the medication.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

UV rays can cause a type of hair loss known as telogen alopecia.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Infertile men are more likely to produce sperm with abnormal chromosome numbers, which can affect pregnancy success and embryo health.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.